皮膚アレルギー治療薬市場：適応症別、投与経路別、治療法別、流通チャネル別-2025-2030年の世界予測

皮膚アレルギー治療薬市場は、2023年に50億4,000万米ドルと評価され、2024年には54億3,000万米ドルに達すると予測され、CAGR 8.15％で成長し、2030年には87億3,000万米ドルに達すると予測されています。

皮膚アレルギー治療薬には、湿疹、じんましん、接触性皮膚炎など、皮膚に現れるアレルギー反応を緩和または治癒するために設計された一連の治療が含まれます。これらの製品には、外用クリーム、内服薬、注射薬が含まれます。これらの治療薬の必要性は、アレルゲンや環境汚染物質への曝露の増加による皮膚アレルギーの有病率の増加から生じています。その用途は、病院、クリニック、在宅ケアなど様々な環境に及び、エンドユーザーは患者個人からヘルスケアプロバイダーまで多岐にわたる。この分野の市場成長は、皮膚の健康に対する意識の高まり、薬剤製剤の技術的進歩、ヘルスケア・インフラへの投資の増加から強い影響を受けています。さらに、生物製剤や個別化医療の開発といった新たな動向は、オーダーメイド治療の新たな道を開き、有効性と患者のコンプライアンスを向上させる。しかし、市場は厳しい規制の枠組み、研究開発コストの高さ、一部の治療薬による副作用やアレルギー反応といった課題に直面しています。オーガニックな解決策を求める顧客の嗜好の高まりに対応するため、天然または低アレルギー性製品の開発などの分野に注力することで、機会を捉えることができます。予測診断と個別化治療計画のためのAIと機械学習の革新は、研究のための肥沃な土壌を提供します。KEYWORD市場は競争が激しいが、医薬品開発を促進するための戦略的パートナーシップや研究協力を通じて成長の可能性があります。また企業は、ヘルスケアに対する意識の高まりから需要が高まっている新興国での製品提供の拡大によっても利益を得ることができます。とはいえ、この分野での成功には、規制上の障壁を効率的に乗り越え、技術の進歩に歩調を合わせるために強固な医薬品パイプラインに投資することが必要です。

市場力学：急速に進化する皮膚アレルギー治療薬市場の主要市場インサイトを公開

皮膚アレルギー治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口における皮膚アレルギー症状の有病率の上昇
  • スキンケアと皮膚アレルギー検出に対する意識の高まり
• 市場抑制要因
  • スキンケア治療に伴う高コスト
• 市場機会
  • 新規テーマ開発のための活発な研究活動
  • ヘルスケアインフラと医療支出の改善
• 市場の課題
  • 治療薬開発に対する厳しい規制要件

ポーターの5つの力：皮膚アレルギー治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：皮膚アレルギー治療薬市場における外部からの影響の把握

外部マクロ環境要因は、皮膚アレルギー治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析皮膚アレルギー治療薬市場における競合情勢の把握

皮膚アレルギー治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス皮膚アレルギー治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、皮膚アレルギー治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨皮膚アレルギー治療薬市場における成功への道筋を描く

皮膚アレルギー治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口における皮膚アレルギー疾患の有病率の上昇
    • スキンケアと皮膚アレルギーの検出に対する意識の高まり
  • 抑制要因
    • スキンケア治療にかかる高額な費用
  • 機会
    • 新規開発に向けた強力な調査活動皮膚アレルギー治療薬
    • ヘルスケアインフラと医療費の改善
  • 課題
    • 治療薬開発に対する厳格な規制要件
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 皮膚アレルギー治療薬市場適応症別

• 血管性浮腫
• 接触性皮膚炎
• 湿疹
• 蕁麻疹

第7章 皮膚アレルギー治療薬市場：投与経路別

• オーラル
• 非経口

第8章 皮膚アレルギー治療薬市場治療別

• 免疫療法
• 経口薬
• 光線療法
• 局所治療

第9章 皮膚アレルギー治療薬市場：流通チャネル別

• オフライン
  • ドラッグストア
  • 小売薬局
• オンライン

第10章 南北アメリカの皮膚アレルギー治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の皮膚アレルギー治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの皮膚アレルギー治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ALK-Abello A/S
• Astellas Pharma International B.V.
• AstraZeneca PLC
• Bausch Health Companies Inc
• Bayer AG
• DBV Technologies Inc.
• Dr.Reddy's Laboratories Limited
• Eisai Co., Ltd.
• Eli Lilly and Company
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Ltd.
• Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
• HYCOR Biomedical, LLC
• Johnson & Johnson Consumer Inc.
• LEO Pharma A/S
• Ligand Pharmaceuticals Incorporated
• Lincoln Diagnostics, Inc.
• Merck KGaA
• Omega Diagnostics Group PLC
• Pfizer Inc.
• Piramal Enterprises Limited
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Synnat Pharma Private Limited
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

LIST OF FIGURES

• FIGURE 1. SKIN ALLERGY THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SKIN ALLERGY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SKIN ALLERGY THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ANGIOEDEMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY CONTACT DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ECZEMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CANADA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. CHINA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 75. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. INDIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 161. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 162. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. ITALY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 184. POLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 186. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 187. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. QATAR SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM SKIN ALLERGY THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 235. SKIN ALLERGY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. SKIN ALLERGY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Skin Allergy Therapeutics Market was valued at USD 5.04 billion in 2023, expected to reach USD 5.43 billion in 2024, and is projected to grow at a CAGR of 8.15%, to USD 8.73 billion by 2030.

Skin allergy therapeutics encompass a range of treatments designed to alleviate or cure allergic reactions manifested on the skin, such as eczema, hives, and contact dermatitis. These products include topical creams, oral medications, and injectables. The necessity for these therapeutics stems from the increasing prevalence of skin allergies due to heightened exposure to allergens and environmental pollutants. Their application spans various settings, including hospitals, clinics, and at-home care, with end users ranging from individual patients to healthcare providers. Market growth in this domain is strongly influenced by rising awareness about skin health, technological advancements in drug formulations, and increasing investments in healthcare infrastructure. Furthermore, emerging trends such as the development of biologics and personalized medicine open new avenues for tailored treatments, enhancing efficacy and patient compliance. However, the market faces challenges such as stringent regulatory frameworks, high R&D costs, and the side effects or allergic reactions caused by some therapeutics. Opportunities can be seized by focusing on areas like the development of natural or hypoallergenic products to cater to the growing customer preference for organic solutions. Innovations in AI and machine learning for predictive diagnosis and personalized treatment plans present a fertile ground for research. The skin allergy therapeutics market is competitive yet offers potential for growth through strategic partnerships and collaborations in research to expedite drug development. Companies can also benefit by expanding their offerings in emerging economies, where there is a rising demand due to increasing healthcare awareness. Nonetheless, success in this sector necessitates navigating regulatory barriers efficiently and investing in robust pharmaceutical pipelines to keep pace with technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Skin Allergy Therapeutics Market

The Skin Allergy Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of skin allergy conditions among population
  • Growing awareness of skincare and detection of skin allergies
• Market Restraints
  • High costs associated with skincare treatments
• Market Opportunities
  • Robust research activities to develop novel skin allergy therapeutics
  • Improved healthcare infrastructure and medical spendings
• Market Challenges
  • Stringent regulatory requirements for therapeutics development

Porter's Five Forces: A Strategic Tool for Navigating the Skin Allergy Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Skin Allergy Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Skin Allergy Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Skin Allergy Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Skin Allergy Therapeutics Market

A detailed market share analysis in the Skin Allergy Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Skin Allergy Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Skin Allergy Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Skin Allergy Therapeutics Market

A strategic analysis of the Skin Allergy Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Skin Allergy Therapeutics Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Astellas Pharma International B.V., AstraZeneca PLC, Bausch Health Companies Inc, Bayer AG, DBV Technologies Inc., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., HYCOR Biomedical, LLC, Johnson & Johnson Consumer Inc., LEO Pharma A/S, Ligand Pharmaceuticals Incorporated, Lincoln Diagnostics, Inc., Merck KGaA, Omega Diagnostics Group PLC, Pfizer Inc., Piramal Enterprises Limited, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Synnat Pharma Private Limited, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Skin Allergy Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Angioedema, Contact Dermatitis, Eczema, and Urticaria.
• Based on Route of Administration, market is studied across Oral and Parenteral.
• Based on Treatment, market is studied across Immunotherapy, Oral Medications, Phototherapy, and Topical Treatments.
• Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Drug Stores and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of skin allergy conditions among population
    • 5.1.1.2. Growing awareness of skincare and detection of skin allergies
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with skincare treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust research activities to develop novel skin allergy therapeutics
    • 5.1.3.2. Improved healthcare infrastructure and medical spendings
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for therapeutics development
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Skin Allergy Therapeutics Market, by Indication

• 6.1. Introduction
• 6.2. Angioedema
• 6.3. Contact Dermatitis
• 6.4. Eczema
• 6.5. Urticaria

7. Skin Allergy Therapeutics Market, by Route of Administration

• 7.1. Introduction
• 7.2. Oral
• 7.3. Parenteral

8. Skin Allergy Therapeutics Market, by Treatment

• 8.1. Introduction
• 8.2. Immunotherapy
• 8.3. Oral Medications
• 8.4. Phototherapy
• 8.5. Topical Treatments

9. Skin Allergy Therapeutics Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline
  • 9.2.1. Drug Stores
  • 9.2.2. Retail Pharmacies
• 9.3. Online

10. Americas Skin Allergy Therapeutics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Skin Allergy Therapeutics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Skin Allergy Therapeutics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ALK-Abello A/S
• 2. Astellas Pharma International B.V.
• 3. AstraZeneca PLC
• 4. Bausch Health Companies Inc
• 5. Bayer AG
• 6. DBV Technologies Inc.
• 7. Dr.Reddy's Laboratories Limited
• 8. Eisai Co., Ltd.
• 9. Eli Lilly and Company
• 10. GlaxoSmithKline PLC
• 11. Glenmark Pharmaceuticals Ltd.
• 12. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
• 13. HYCOR Biomedical, LLC
• 14. Johnson & Johnson Consumer Inc.
• 15. LEO Pharma A/S
• 16. Ligand Pharmaceuticals Incorporated
• 17. Lincoln Diagnostics, Inc.
• 18. Merck KGaA
• 19. Omega Diagnostics Group PLC
• 20. Pfizer Inc.
• 21. Piramal Enterprises Limited
• 22. Sanofi S.A.
• 23. Sun Pharmaceutical Industries Ltd.
• 24. Synnat Pharma Private Limited
• 25. Teva Pharmaceutical Industries Ltd.
• 26. Viatris Inc.